Bioventus Inc (BVS) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.06x
Bioventus Inc (BVS) has a Cash Flow Reinvestment Rate of 0.06x as of March 2026, reinvesting $574.00K (capex $574.00K ) from operating cash flow of $8.93 Million. Check Bioventus Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.06x
(Capex + Investments) / Operating CF
Total Reinvested
$574.00K
Capex + Investments
Operating Cash Flow
$8.93 Million
USD
Capital Expenditures
$574.00K
USD
Bioventus Inc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Bioventus Inc across 10 annual periods. Explore BVS long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Bioventus Inc (2013–2025)
Year-by-year capital reinvestment analysis for Bioventus Inc. For live market cap and broader valuation context, see Bioventus Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | $2.56 Million | $73.98 Million | $2.56 Million | ▼ -94.4% |
| 2024 | 0.62x | $23.97 Million | $38.80 Million | $1.01 Million | ▼ -53.4% |
| 2023 | 1.33x | $20.36 Million | $15.34 Million | $7.36 Million | ▲ +46.0% |
| 2021 | 0.91x | $20.89 Million | $22.99 Million | $7.37 Million | ▲ +58.5% |
| 2020 | 0.57x | $41.17 Million | $71.80 Million | $20.67 Million | ▲ +43.6% |
| 2019 | 0.40x | $16.25 Million | $40.71 Million | $8.34 Million | ▲ +48.3% |
| 2018 | 0.27x | $12.16 Million | $45.19 Million | $6.06 Million | ▼ -31.6% |
| 2015 | 0.39x | $7.44 Million | $18.92 Million | $7.44 Million | ▼ -71.5% |
| 2014 | 1.38x | $20.83 Million | $15.11 Million | $20.83 Million | ▼ -40.4% |
| 2013 | 2.31x | $6.36 Million | $2.75 Million | $6.36 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow